NASH – A CHRONIC AND SERIOUS DISEASE

Society: DDW

This presentation will explore the pathophysiology of nonalcoholic steatohepatitis (NASH), including the impact of underlying comorbidities. We will also discuss the importance of early diagnosis and intervention for high-risk patients, review current management strategies and highlight the need for future therapies specific to NASH. Sponsored by Novo Nordisk